fh tirzepatide Beyond glycemia: Comparing to GLP-1 analogues | Reviews in Endocrine and Metabolic Disorders Tirzepatide | GoodGirlRx

10: e77772

Future studies should focus on elucidating the complex interactions within the somatosensory system and developing targeted therapies based on advanced imaging and molecular insights

Onitilo, A

This observation has raised concerns regarding suboptimal drug exposure, altered pharmacokinetics, and heightened inflammatory burden in obese patients, highlighting the potential need for dose optimization or alternative treatment strategies in this population ( The impact of BMI on treatment response is well illustrated by the AQUILA study, which examined real-world outcomes in PsA patients treated with ( However, the relationship between BMI and response to biologic therapies is not uniformly consistent across studies